| |
| |
|
| Insider
Information: |
Mosseri Marlio Charles |
| Relationship: |
10% Owner |
| City: |
London |
| State: |
N1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,595,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,595,000 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvectis Pharma, Inc. |
NVCT |
10% Owner |
2023-07-31 |
2,595,000 |
2023-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-31 |
4 |
B |
$13.88 |
$11,937 |
D/D |
860 |
2,595,000 |
2.37 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-28 |
4 |
B |
$13.91 |
$35,943 |
D/D |
2,584 |
2,594,140 |
2.37 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-27 |
4 |
B |
$13.98 |
$21,753 |
D/D |
1,556 |
2,591,556 |
2.37 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-26 |
4 |
B |
$13.97 |
$139,700 |
D/D |
10,000 |
2,590,000 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-21 |
4 |
B |
$14.61 |
$41,551 |
D/D |
2,844 |
2,580,000 |
2.37 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-20 |
4 |
B |
$14.40 |
$77,674 |
D/D |
5,394 |
2,577,156 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-19 |
4 |
B |
$14.84 |
$118,720 |
D/D |
8,000 |
2,571,762 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-18 |
4 |
B |
$14.84 |
$135,771 |
D/D |
9,149 |
2,563,762 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-12 |
4 |
B |
$15.09 |
$49,571 |
D/D |
3,285 |
2,554,613 |
2.37 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-11 |
4 |
B |
$15.36 |
$153,600 |
D/D |
10,000 |
2,551,328 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-07 |
4 |
B |
$15.19 |
$135,920 |
D/D |
8,948 |
2,541,328 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-06 |
4 |
B |
$15.01 |
$47,717 |
D/D |
3,179 |
2,532,380 |
2.37 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-07-05 |
4 |
B |
$15.52 |
$18,252 |
D/D |
1,176 |
2,529,201 |
2.37 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-06-26 |
4 |
B |
$16.46 |
$275,870 |
D/D |
16,760 |
2,528,025 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-06-23 |
4 |
B |
$17.43 |
$1,275,440 |
D/D |
73,175 |
2,511,265 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-06-22 |
4 |
B |
$17.73 |
$124,092 |
D/D |
6,999 |
2,438,090 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-06-21 |
4 |
B |
$17.71 |
$107,872 |
D/D |
6,091 |
2,431,091 |
2.45 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
10% Owner |
– – • |
2023-06-15 |
4 |
B |
$17.54 |
$568,848 |
D/D |
32,124 |
2,412,300 |
2.45 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
